| ²é¿´: 2280 | »Ø¸´: 9 | |||||
885511ľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
ÎÄÕ±»Pharmazie ¾Ü¸å£¬ÇóÖúҩѧ·½ÃæµÄÈÝÒ×Ò»µãµÄSCI»òÕßSCIE£¬·Ç³£¸Ðл£¡
|
|
ÎÄÕ±»Pharmazie ¾Ü¸å£¬ÇóÖúҩѧ·½ÃæµÄÈÝÒ×Ò»µãµÄSCI»òÕßSCIE£¬·Ç³£¸Ðл£¡ ×öµÄÊÇÒ©ÎïÈܳö·½ÃæµÄ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
Ò©Îﻯѧ-ºÏ³É£¬ÆÚ¿¯ | ÊÕÎÒËùϧ£¬²ØÎÒËù°® | Ò©»¯ÓлúͶ¸åרÓÃÌù |
» ²ÂÄãϲ»¶
ÈËÆø²»ÐÐÁË
ÒѾÓÐ9È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ6È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ5È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ19È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ21È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ16È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ9È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µÚһƪSCI±»¾ÜÁË..ÇóÖú°¡....
ÒѾÓÐ34È˻ظ´
Çë¿ÆÑÐÕ½¼¨µÄÅóÓÑÃǰïæ·ÖÎöһϣº·µÐÞµÄSCIÂÛÎÄ£¬Èç¹û¸ÄÊý¾Ý»áÔì³É¾Ü¸åÂð£¿
ÒѾÓÐ4È˻ظ´
ÎÄÕ±»¾ÜÁË£¬ÏëÖØÐÂͶ¸å£¬ÓÐÈÝÒ×ÖеÄSCIÔÓÖ¾¿ÉÒÔÍÆ¼ö¸öÂð£¿Ð»Ð»ÁË£¡
ÒѾÓÐ4È˻ظ´
ҩѧ¡¢Ò©Îﻯѧ¡¢Ò©¼Áѧ¡¢Ò©Àíѧ¡¢Ò©Îï·ÖÎö¡¢ÉúÎïÖÆÒ©¡¢ÖÐÒ©SCIÆÚ¿¯£ºpharmazie
ÒѾÓÐ30È˻ظ´
ÇëÎÊPHARMAZIEÊÇSCI»¹ÊÇSCIE£¬Ð»Ð»£¡
ÒѾÓÐ6È˻ظ´
SCIEÊÕ¼µÄÎÄÕ£¬¼ìË÷½á¹ûÓëSCIÎÄÕ¼ìË÷½á¹ûÓÐʲô²»Í¬Âð£¬Ð»Ð»¡£
ÒѾÓÐ18È˻ظ´
Ò²À´ËµËµÎҵĵÚһƪSCI°É£¨¾ÀúÇúÕÛ£¬Ï£Íû¸ø³õ´ÎͶ¸åµÄÈËÒ»µã½è¼ø£©
ÒѾÓÐ72È˻ظ´
SCIEËãÊÇSCIÎÄÕÂÂð£¿
ÒѾÓÐ33È˻ظ´
ÊDz»ÊǽøÁËSCIEµÄ¿¯ÎïµÄËùÓÐÎÄÕ¶¼»á±»SCI¼ìË÷£¿
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú¡¿ÇëÎʿ󴲵ØÇò»¯Ñ§·½ÃæµÄ¹úÍâSCIÄĸöÈÝÒ×·¢±í°¡£¿
ÒѾÓÐ14È˻ظ´
885511
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1541.1
- É¢½ð: 4
- ºì»¨: 3
- Ìû×Ó: 1095
- ÔÚÏß: 222.1Сʱ
- ³æºÅ: 61325
- ×¢²á: 2005-03-11
- רҵ: Ò©Îï·ÖÎö
¡ï
avast2009(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-12-03 09:20:52
avast2009(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-12-03 09:20:52
|
Òâ¼û was carefully evaluated by the editors. According to the results of this process, it was decided that the manuscript is not suitable for publication our journal. This paper should be submitted to a more specialized journal. The general pharmaceutical relevance is fairly low. Therefore we cannot accept this paper for publication. Lately we receive too many manuscripts which forces us to select carefully those which will be published. This strict selection is required to manage reasonable time intervals from submission to publication. |
2Â¥2011-12-02 23:24:49
885511
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1541.1
- É¢½ð: 4
- ºì»¨: 3
- Ìû×Ó: 1095
- ÔÚÏß: 222.1Сʱ
- ³æºÅ: 61325
- ×¢²á: 2005-03-11
- רҵ: Ò©Îï·ÖÎö
3Â¥2011-12-03 12:02:19
wu3833145
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 5579.6
- Ìû×Ó: 666
- ÔÚÏß: 497.2Сʱ
- ³æºÅ: 622285
- ×¢²á: 2008-10-10
- רҵ: ʳƷ¼Ó¹¤¼¼Êõ
4Â¥2011-12-11 14:58:01
leimiao_hit
ľ³æÖ®Íõ (ÎÄѧ̩¶·)
СԪ
- SEPI: 7
- Ó¦Öú: 1336 (½²Ê¦)
- ¹ó±ö: 0.707
- ½ð±Ò: 113738
- É¢½ð: 12354
- ºì»¨: 385
- ɳ·¢: 888
- Ìû×Ó: 85000
- ÔÚÏß: 6307.5Сʱ
- ³æºÅ: 1264338
- ×¢²á: 2011-04-13
- רҵ: Êß²ËѧÓë¹Ï¹ûѧ

5Â¥2011-12-11 15:15:02
885511
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1541.1
- É¢½ð: 4
- ºì»¨: 3
- Ìû×Ó: 1095
- ÔÚÏß: 222.1Сʱ
- ³æºÅ: 61325
- ×¢²á: 2005-03-11
- רҵ: Ò©Îï·ÖÎö
6Â¥2011-12-12 21:46:14
zhenglei8501
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 2861.8
- Ìû×Ó: 295
- ÔÚÏß: 102Сʱ
- ³æºÅ: 270291
- ×¢²á: 2006-08-06
- ÐÔ±ð: GG
- רҵ: Ò©Îïѧ
7Â¥2012-01-12 16:26:41
885511
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1541.1
- É¢½ð: 4
- ºì»¨: 3
- Ìû×Ó: 1095
- ÔÚÏß: 222.1Сʱ
- ³æºÅ: 61325
- ×¢²á: 2005-03-11
- רҵ: Ò©Îï·ÖÎö
8Â¥2012-01-12 18:47:54
zhenglei8501
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 2861.8
- Ìû×Ó: 295
- ÔÚÏß: 102Сʱ
- ³æºÅ: 270291
- ×¢²á: 2006-08-06
- ÐÔ±ð: GG
- רҵ: Ò©Îïѧ
9Â¥2012-01-12 19:06:15
885511
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 1541.1
- É¢½ð: 4
- ºì»¨: 3
- Ìû×Ó: 1095
- ÔÚÏß: 222.1Сʱ
- ³æºÅ: 61325
- ×¢²á: 2005-03-11
- רҵ: Ò©Îï·ÖÎö
10Â¥2012-01-12 19:27:29









»Ø¸´´ËÂ¥
20